Skip to main content

Mini Nicotine

NDC 68016-087 · Chain Drug Consortium, LLC

Generic namenicotine polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

68016-087-81 — 3 BOTTLE, PLASTIC in 1 BOX (68016-087-81) / 27 LOZENGE in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63981-873 — Nicotine Polacrilex, 66715-8123 — nicotine polacrilex, 66715-8124 — nicotine polacrilex, 66715-8125 — nicotine polacrilex, 68001-432 — Nicotine Transdermal System, 68001-433 — Nicotine Transdermal System, 68001-434 — Nicotine Transdermal System, 68001-697 — Nicotine Transdermal System Patch, 68001-698 — Nicotine Transdermal System Patch, 68001-699 — Nicotine Transdermal System Patch, 68016-280 — Nicotine Polacrilex, 68016-281 — Nicotine Polacrilex, 68016-284 — Nicotine Polacrilex, 68016-285 — Nicotine Polacrilex, 68016-286 — Nicotine Polacrilex, 68016-287 — Nicotine Polacrilex, 68016-292 — Nicotine Polacrilex, 68016-293 — Nicotine Polacrilex, 68016-559 — Nicotine Polacrilex, 68016-560 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels